metaPreg - Liraglutide during pregnancy

Liraglutide updated on 01-05-2026

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	0.74 [0.20, 2.72]	-	1 study	17	55	not evaluable	ROB	-
Major congenital malformations	0.74 [0.20, 2.72]	-	1 study	17	55	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	-	-	0 study					-
Large for gestational age (weight)	-	-	0 study					-
Small for gestational age (weight)	-	-	0 study					-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	-	-	0 study					-
Gestational diabetes	-	-	0 study					-
Preeclampsia	-	-	0 study					-
Hide endpoints reported in only one study ...